PHA-739358 for the Treatment of Multiple Myeloma
The purpose of this study is to determine the antitumor activity of PHA-739358 as single agent IV infusion in adult patients with Multiple Myeloma who have a history of at least 2 previous lines of treatment for the disease.
Multiple Myeloma
DRUG: PHA-739358
Response Rate according to International Myeloma Working Group uniform response criteria for multiple myeloma., At end of each cycle
Overall safety profile, All cycles
The purpose of this study is to determine the antitumor activity of PHA-739358 as single agent IV infusion in adult patients with Multiple Myeloma who have a history of at least 2 previous lines of treatment for the disease.